No Picture
News

News briefing: AbbVie partner Teneobio expands tech license with CAR-T player Poseida; Argenx buys PRV from Bayer for $98M

Eric Ostertag
Teneobio may be best known for its pact with AbbVie and Gilead, but before its big break the bispecific player had licensed its antibodies for a different use: as binders in CAR-T therapies being developed by Poseida.
Now, the biotechs ar… […]

No Picture
News

Amgen severs 14-year Cytokinetics partnership, bailing on omecamtiv after mixed PhIII results

Amgen is shrugging off a 14-year development alliance and the tens of millions of dollars spent to develop a new heart drug at Cytokinetics after a Phase III trial turned up weak data — leaving Cytokinetics to soldier on alone.
Omecamtiv mecarbil techn… […]

No Picture
News

Ancestry® Offers Opportunity to Explore Family Stories for Free This Thanksgiving Weekend to Bring Families Together During an Unprecedented Holiday Season

LEHI, Utah & SAN FRANCISCO–(BUSINESS WIRE)–To help Americans feel more connected, even when they may be apart this holiday season, Ancestry®, the global leader in family history, is offering everyone free access to personalized stories from Thank… […]

No Picture
News

From a pair of Air Jordans to a $200M-plus IPO, Carl Hansen is crafting an overnight R&D fortune fueled by Covid-19

Back in the summer of 2019, Carl Hansen left his post as a professor at the University of British Columbia to go full time as the CEO at a low-profile antibody shop he had founded called AbCellera.
As biotech CEOs go, even after a fundraise Hansen wasn… […]

No Picture
News

Brightseed Partners with Pharmavite for Artificial Intelligence-Powered Discovery of Novel Phytonutrients

The partnership will expand Pharmavite’s evidence-based research and development pipeline for new product innovations

SAN FRANCISCO, Nov. 23, 2020 /PRNewswire/ — Brightseed, developer of Forager® AI, and Pharmavite LLC, a leader in the health and we… […]